Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print September 5, 2008
DOI: 10.2337/db07-1690

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Proulx, K.
Right arrow Articles by Seeley, R. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Proulx, K.
Right arrow Articles by Seeley, R. J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

FATTY ACID SYNTHASE (FAS) INHIBITORS MODULATE ENERGY BALANCE VIA MTOR COMPLEX 1 (MTORC1) SIGNALING IN THE CENTRAL NERVOUS SYSTEM (CNS)

Karine Proulx, PhD1, Daniela Cota, MD1, Stephen C. Woods, PhD1, and Randy J. Seeley, PhD1

1Department of Psychiatry, University of Cincinnati, Genome Research Institute, Cincinnati, Ohio 45237, USA

Objective: Evidence links the hypothalamic fatty acid synthase (FAS) pathway to the regulation of food intake and body weight. This includes pharmacological inhibitors that potently reduce feeding and body weight. The mammalian target of rapamycin (mTOR) is an intracellular fuel sensor whose activity in the hypothalamus is also linked to the regulation of energy balance. The purpose of these experiments was to determine whether hypothalamic mTORC1 signaling is involved in mediating the effects of FAS inhibitors.

Research Design and Methods: We measured the hypothalamic phosphorylation of two downstream targets of mTORC1, S6 kinase 1 (S6K1) and S6 ribosomal protein (S6), following administration of the FAS inhibitors C75 and cerulenin in rats. We evaluated food intake in response to FAS inhibitors in rats pretreated with the mTOR inhibitor rapamycin, and in mice lacking functional S6K1 (S6K1–/–). Food intake and phosphorylation of S6K1 and S6 were also determined following C75 injection in rats maintained on a ketogenic diet.

Results: C75 and cerulenin increased phosphorylation of S6K1 and S6 and their anorexic action was reduced in rapamycin-treated rats and in S6K1–/– mice. Consistent with our previous findings, C75 was ineffective at reducing caloric intake in ketotic rats. Under ketosis, C75 was also less efficient at stimulating mTORC1 signaling.

Conclusions: These findings collectively indicate an important interaction between the FAS and mTORC1 pathways in the central nervous system (CNS) to regulate energy balance, possibly via modulation of neuronal glucose utilization.


Correspondence: randy.seeley{at}uc.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.